This information was published on 2026-05-15T14:23:47 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2612860 |
| (220) |
17 Dec 2025
|
| (300) |
US, 09 Oct 2025, 99435673
|
| (511) (510) |
Class 1
Diagnostic agents, reagents, assays, enzymes, nucleotides, and buffers [chemicals] for scientific and research use; Diagnostic agents, reagents, assays, enzymes, nucleotides, and buffers [chemicals] for scientific and research use, in the fields of genetic sequencing, genotyping, genomics, genetic testing, and nucleic acid sequencing; Chemical reagents for sequencing DNA, RNA, and nucleic acids, for research and scientific purposes; Diagnostic test kits containing reagents, enzymes, assays, buffers and flow cells for non-medical purposes; Diagnostic kits comprising chemical reagents, DNA sequences, nucleic acids, enzymes, nucleotides, and flow cell cartridges, all for research, scientific, and industrial purposes; Chemical agents and reagents used in scientific and research genetic sequencing to identify and expand scope of sequenced material Class 5 Diagnostic agents, reagents, assays, enzymes, nucleotides, and buffers for medical, dental, and veterinary use in the fields of genetic sequencing, genotyping, genomics, genetic testing, and nucleic acid sequencing; Chemical reagents for sequencing DNA, RNA, and nucleic acids, for medical purposes; Diagnostic kits containing reagents, agents, enzymes, assays, buffers and flow cells for medical purposes in the fields of genetic sequencing, genotyping, metagenomics, genetic testing, and nucleic acid sequencing; Diagnostic kits comprising chemical reagents, DNA sequences, nucleic acids, enzymes, nucleotides, and flow cell cartridges, for medical purposes in the fields of genetic sequencing, genotyping, metagenomics, genetic testing, and nucleic acid sequencing; Chemical agents and reagents for genetic sequencing to identify and expand scope of sequenced material for medical purposes in the field of genetic sequencing, genotyping, metagenomics, genetic testing, and nucleic acid sequencing |
| (540) | TRUPATH |
| (550) | Word |
| (730) |
Illumina, Inc.
|
| (750) |
Addisons Lawyers
|
Find out more about publications on the About page.